Giovanni Caforio

Track

Insider profile

Currently holds a position at Bristol-Myers Squibb Co

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 72% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, Chief Executive Officer Bristol-Myers Squibb Co May 2, 2017 -
Chief Executive Officer, Director Bristol-Myers Squibb Co May 5, 2015 - May 2, 2017
Chief Executive Officer, Director Bristol-Myers Squibb Co June 5, 2014 - May 5, 2015
Chief Operating Officer, Director Bristol-Myers Squibb Co June 5, 2014 - May 5, 2015
Executive Vice President, Chief Commercial Officer Bristol-Myers Squibb Co Nov. 13, 2013 - June 5, 2014
President, U.S. Pharmaceuticals Bristol-Myers Squibb Co Oct. 19, 2011 - Nov. 13, 2013
Giovanni Caforio's trades of Yakkyo SpA's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
IT Yakkyo SpA (YKY)
Transaction date
Sale
Price
310.44
Quantity 22,956
Value €3,144,642
Transaction date
Sale
Price
67.00
Quantity 30,000 -6.2%
Value US$2,010,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-02 2026-02-26
IT Yakkyo SpA (YKY)
S Sale
22,956
310.44
€3,144,642 		22,956 310.44 €3,144,642
2023-02-08 2023-02-06
S Sale
98,193 -3.4%
37.32
US$229,280 		98,193 -3.4% 37.32 US$229,280
2022-09-22 2022-09-20
PlS Planned sale
91,881 +6.4%
267.51
US$3,488,141 		91,881 +6.4% 267.51 US$3,488,141
2022-09-16 2022-09-15
S Sale
50,000 -9.1%
71.84
US$3,592,000 		50,000 -9.1% 71.84 US$3,592,000
2022-06-14 2022-06-13
S Sale
30,000 -5.2%
74.04
US$2,221,200 		30,000 -5.2% 74.04 US$2,221,200
2022-03-23 2022-03-21
PlS Planned sale
25,000 -4.1%
71.52
US$1,788,000 		25,000 -4.1% 71.52 US$1,788,000
2022-02-28 2022-02-24
S Sale
30,000 -6.2%
67.00
US$2,010,000 		30,000 -6.2% 67.00 US$2,010,000
2021-03-24 2021-03-22
PlS Planned sale
25,000 -4.5%
62.20
US$1,555,000 		25,000 -4.5% 62.20 US$1,555,000
2020-09-02 2020-08-31
S Sale
39,840 -8.2%
62.70
US$2,497,968 		39,840 -8.2% 62.70 US$2,497,968